NCI
Rank #111Rank #111 by gross profitability (GP/assets 0.44) · ROE 0.6% · Piotroski F-Score 6 / 9.
As-of 2026-07-22 · CIK 0001916331 · all metrics point-in-time as of the filing date.
Financials
Stable
Direction over 5 fiscal years
- Free cash flowimproving
- Gross marginimproving
- Gross profitabilitystable
- Net cashimproving
- Operating margindeteriorating
- Return on equityimproving
- Share count (dilution)deteriorating
Monitoring diagnostic of business direction — not a prediction of returns.
Each fiscal year is read as-of that year’s own 10-K filing, so nothing restated after the fact leaks backwards. Line items this filer never tagged are omitted. Hover or tap a badge for the diagnostic behind it.
| Fiscal year end | 2025-12-31filed 2026-04-30 | 2024-12-31filed 2025-05-15 | 2023-12-31filed 2024-05-14 | 2022-12-31filed 2024-05-14 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | 137.2 | 235.7 | 174.2 | 347.5 |
| Revenue growth (YoY) | -41.8% | 35.3% | -49.9% | -49.9% |
| Gross profit | 50.7 | 49.4 | 35.0 | 35.0 |
| Gross margin | 36.9% | 21.0% | 20.1% | 20.1% |
| Net income | 0.3 | 8.1 | 4.4 | 12.4 |
| Net margin | 0.2% | 3.4% | 2.5% | 2.5% |
| EPS (diluted) | $0.08 | $0.41 | $0.25 | $0.69 |
| EPS growth (YoY) | -80.5% | 64.0% | -63.8% | — |
| Cash flow | ||||
| Operating cash flow | 21.4 | 0.4 | (49.2) | (42.8) |
| Capital expenditures | 4.0 | 4.1 | 1.3 | — |
| Free cash flow | 17.4 | (3.7) | (50.5) | (50.5) |
Figures are as originally filed with the SEC (point-in-time), not restated, so they can differ slightly from sites that show later-restated numbers. Why point-in-time?